JMI Hospital Requisite Mfg. Ltd. submitted auditor's report regarding status of IPO (Initial Public Offering) Proceeds utilization statement for the Period from 01 April 2026 to 30 June 2026. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/JMI%20Hospital826.pdf

JMI Hospital Requisite Manufacturing Ltd. submitted auditor's report regarding status of IPO (Initial Public Offering) Proceeds utilization statement for the period from 01 January 2026 to March 31, 2026. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/JMI26.pdf

(Cont. News of JHRML): Reasons for Deviation: EPS has decreased because imported raw materials purchases are at high prices compared with sales in the local market (end)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2026 at 4:00 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended March 31, 2026.

The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2025 to the respective shareholders.

JMI Hospital Requisite Mfg. Ltd. submitted auditor's report regarding status of IPO (Initial Public Offering) Proceeds utilization statement for the period from 01 October 2025 to 31 December, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/JMI%20Hospital%20Requisite_25.pdf

(Cont. News of JHRML): Reasons for deviation: EPS decreased because imported raw material purchases are at high prices compared with sales in the local market. (end)

The company has informed that the shareholders at its 17th AGM held on January 22, 2026, approved the revision of IPO proceeds utilization along with an extension of time up to December 31, 2026. To view details, please visit the following link: https://www.dsebd.org/Annexure/2025/PSI_17th_AGM_IPO_Proceeds_JMI_2026.pdf

The Company will be placed in 'B' category from existing 'A' category with effect from January 25, 2026 as the Company has approved 5% Cash Dividend for the year ended June 30, 2025.

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 27, 2026 at 3:30 PM to consider, among others, Un-Audited Financial Statements for the Second Quarter (Q2) period ended December 31, 2025.